recipharm advanced bio
PrivateLast Round
Take Private
Feb 15, 2021
Last Round Size
$2.28B
Est. Valuation
$3B
Total Funding Raised
$2.82B
Company Overview
A contract development and manufacturing organization (CDMO) focused on advanced therapy medicinal products (ATMPs).
Historical Pricing
Historical view of private secondary pricing and transaction trends.
recipharm advanced bio Comparables
Compare recipharm advanced bio with similar companies based on industry and business-model similarity.
recipharm advanced bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Take Private | Feb 15, 2021 | ||||
| Follow-on Offering | May 27, 2020 | ||||
| Follow-on Offering | May 19, 2016 | ||||
| IPO | Apr 3, 2014 | ||||
| Buyout/LBO | Mar 1, 1995 |
recipharm advanced bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about recipharm advanced bio's valuation, stock price, and market status.